Monitoring heparin anticoagulation in the acute phase response

British Journal of Haematology

Volumn 149, Issue 4, 2010, Pages 613-619

  Uprichard, James ^a,c   Manning, Richard A ^b   Laffan, Michael A ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

Acute phase; FVIII; Heparin resistance; Thrombelastography; Thrombin generation

Indexed keywords

BLOOD CLOTTING FACTOR 10A ANTIBODY; BLOOD CLOTTING FACTOR 8; HEPARIN; PROTEIN ANTIBODY; THROMBIN; UNCLASSIFIED DRUG;

ACUTE PHASE RESPONSE; ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG MEGADOSE; DRUG MONITORING; DRUG RESISTANCE; HEMATOLOGICAL PARAMETERS; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOELASTOGRAPHY;

ACUTE-PHASE REACTION; ANTICOAGULANTS; BLOOD COAGULATION TESTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG MONITORING; DRUG RESISTANCE; FACTOR VIII; FACTOR XA; HEPARIN; HUMANS; MALE; PARTIAL THROMBOPLASTIN TIME; THROMBELASTOGRAPHY; THROMBIN;

EID: 77951668099     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/j.1365-2141.2010.08129.x     Document Type: Article

References (16)

1. Attia, J., Ray, J.G., Cook, D.J., Douketis, J., Ginsberg, J.S. Geerts, W.H. (2001) Deep vein thrombosis and its prevention in critically ill adults. Archives of Internal Medicine, 161, 1268 1279. (Pubitemid 32679576)
2. Baglin, T., Barrowcliffe, T.W., Cohen, A. Greaves, M. (2006) Guidelines on the use and monitoring of heparin. British Journal of Haematology, 133, 19 34. (Pubitemid 43327194)
3. Basu, D., Gallus, A., Hirsh, J. Cade, J. (1972) A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. New England Journal of Medicine, 287, 324 327.
4. Fernandez, F., N'Guyen, P., Van Ryn, J., Ofosu, F.A., Hirsh, J. Buchanan, M.R. (1986) Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect. Thrombosis Research, 43, 491 495. (Pubitemid 16064365)
5. Geerts, W. Selby, R. (2003) Prevention of venous thromboembolism in the ICU. Chest, 124, 357S 363S. (Pubitemid 38005462)
6. Hemker, H.C. Beguin, S. (2000) Phenotyping the clotting system. Thrombosis and Haemostasis, 84, 747 751.
7. Hirsh, J., van Aken, W.G., Gallus, A.S., Dollery, C.T., Cade, J.F. Yung, W.L. (1976) Heparin kinetics in venous thrombosis and pulmonary embolism. Circulation, 53, 691 695.
8. Hirsh, J., Bauer, K.A., Donati, M.B., Gould, M., Samama, M.M. Weitz, J.I. (2008) Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 133, 141S 159S. (Pubitemid 351892966)
9. Hull, R.D., Raskob, G.E., Hirsh, J., Jay, R.M., Leclerc, J.R., Geerts, W.H., Rosenbloom, D., Sackett, D.L., Anderson, C., Harrison, L. Gent, M. (1986) Continuous intravenous heparin compared with intermittent subcutaneous heparin in the initial treatment of proximal-vein thrombosis. New England Journal of Medicine, 315, 1109 1114. (Pubitemid 17178958)
10. Lagerstedt, C.I., Olsson, C.G., Fagher, B.O., Oqvist, B.W. Albrechtsson, U. (1985) Need for long-term anticoagulant treatment in symptomatic calf-vein thrombosis. Lancet, 2, 515 518.
11. Levine, M.N., Hirsh, J., Gent, M., Turpie, A.G., Cruickshank, M., Weitz, J., Anderson, D. Johnson, M. (1994) A randomized trial comparing activated thromboplastin time with heparin assay in patients with acute venous thromboembolism requiring large daily doses of heparin. Archives of Internal Medicine, 154, 49 56. (Pubitemid 24018101)
12. Morabia, A. (1986) Heparin doses and major bleedings. Lancet, 1, 1278 1279. (Pubitemid 16112336)
13. Olson, J.D., Arkin, C.F., Brandt, J.T., Cunningham, M.T., Giles, A., Koepke, J.A. Witte, D.L. (1998) College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy. Archives of Pathology and Laboratory Medicine, 122, 782 798. (Pubitemid 28411236)
14. Raschke, R.A., Reilly, B.M., Guidry, J.R., Fontana, J.R. Srinivas, S. (1993) The weight-based heparin dosing nomogram compared with a "standard care" nomogram. A randomized controlled trial. Annals of Internal Medicine, 119, 874 881. (Pubitemid 23316870)
15. Schulman, S., Beyth, R.J., Kearon, C. Levine, M.N. (2008) Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 133, 257S 298S. (Pubitemid 351892969)
16. Young, E., Prins, M., Levine, M.N. Hirsh, J. (1992) Heparin binding to plasma proteins, an important mechanism for heparin resistance. Thrombosis and Haemostasis, 67, 639 643.